441 related articles for article (PubMed ID: 24930079)
1. [Diagnosis of acute heart failure and relevance of biomarkers in elderly patients].
Ruiz Ortega RA; Manzano L; Montero-Pérez-Barquero M
Med Clin (Barc); 2014 Mar; 142 Suppl 1():20-5. PubMed ID: 24930079
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of tissue Doppler echocardiography in the diagnosis of new-onset congestive heart failure in patients with levels of B-type natriuretic peptide in the midrange and normal left ventricular ejection fraction.
Arques S; Roux E; Sbragia P; Pieri B; Gelisse R; Ambrosi P; Luccioni R
Echocardiography; 2006 Sep; 23(8):627-34. PubMed ID: 16970713
[TBL] [Abstract][Full Text] [Related]
3. Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction.
de Denus S; Lavoie J; Ducharme A; O'Meara E; Racine N; Sirois MG; Neagoe PE; Zhu L; Rouleau JL; White M
Can J Cardiol; 2012; 28(1):62-8. PubMed ID: 22104539
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers in acute heart failure.
Mallick A; Januzzi JL
Rev Esp Cardiol (Engl Ed); 2015 Jun; 68(6):514-25. PubMed ID: 25911167
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of new-onset heart failure outpatients and collagen biomarkers.
Sanchis L; Andrea R; Falces C; Llopis J; Morales-Ruiz M; López-Sobrino T; Pérez-Villa F; Sitges M; Sabate M; Brugada J
Eur J Clin Invest; 2015 Aug; 45(8):842-9. PubMed ID: 26077878
[TBL] [Abstract][Full Text] [Related]
6. Novel biomarkers in heart failure with preserved ejection fraction.
Shah KS; Maisel AS
Heart Fail Clin; 2014 Jul; 10(3):471-9. PubMed ID: 24975910
[TBL] [Abstract][Full Text] [Related]
7. Clinical Application of Biomarkers in Heart Failure with a Preserved Ejection Fraction: A Review.
Garg A; Virmani D; Agrawal S; Agarwal C; Sharma A; Stefanini G; Kostis JB
Cardiology; 2017; 136(3):192-203. PubMed ID: 27784010
[TBL] [Abstract][Full Text] [Related]
8. Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure.
van Kimmenade RR; Januzzi JL; Ellinor PT; Sharma UC; Bakker JA; Low AF; Martinez A; Crijns HJ; MacRae CA; Menheere PP; Pinto YM
J Am Coll Cardiol; 2006 Sep; 48(6):1217-24. PubMed ID: 16979009
[TBL] [Abstract][Full Text] [Related]
9. Non-natriuretic peptide biomarkers in heart failure with preserved and reduced ejection fraction.
Oikonomou E; Vogiatzi G; Tsalamandris S; Mourouzis K; Siasos G; Lazaros G; Skotsimara G; Marinos G; Vavuranakis M; Tousoulis D
Biomark Med; 2018 Jul; 12(7):783-797. PubMed ID: 29865857
[TBL] [Abstract][Full Text] [Related]
10. Heart failure with anemia: novel findings on the roles of renal disease, interleukins, and specific left ventricular remodeling processes.
O'Meara E; Rouleau JL; White M; Roy K; Blondeau L; Ducharme A; Neagoe PE; Sirois MG; Lavoie J; Racine N; Liszkowski M; Madore F; Tardif JC; de Denus S;
Circ Heart Fail; 2014 Sep; 7(5):773-81. PubMed ID: 25027873
[TBL] [Abstract][Full Text] [Related]
11. Fibrosis marker syndecan-1 and outcome in patients with heart failure with reduced and preserved ejection fraction.
Tromp J; van der Pol A; Klip IT; de Boer RA; Jaarsma T; van Gilst WH; Voors AA; van Veldhuisen DJ; van der Meer P
Circ Heart Fail; 2014 May; 7(3):457-62. PubMed ID: 24647119
[TBL] [Abstract][Full Text] [Related]
12. Circulating biomarkers in patients with heart failure and preserved ejection fraction.
O'Meara E; de Denus S; Rouleau JL; Desai A
Curr Heart Fail Rep; 2013 Dec; 10(4):350-8. PubMed ID: 24122286
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of natriuretic peptides in the differential diagnosis of dyspnea].
Špác J
Vnitr Lek; 2016; 62(7-8):640-5. PubMed ID: 27627091
[TBL] [Abstract][Full Text] [Related]
14. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides.
Maeder M; Fehr T; Rickli H; Ammann P
Chest; 2006 May; 129(5):1349-66. PubMed ID: 16685029
[TBL] [Abstract][Full Text] [Related]
15. [Natriuretic peptides--new diagnostic markers in heart disease].
Angermann CE; Ertl G
Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
[TBL] [Abstract][Full Text] [Related]
16. Galectin-3, a prognostic marker--and a therapeutic target?
Pereira AR; Menezes Falcão L
Rev Port Cardiol; 2015 Mar; 34(3):201-8. PubMed ID: 25746675
[TBL] [Abstract][Full Text] [Related]
17. Multiple biomarker strategy based on parathyroid hormone and natriuretic peptides testing for improved prognosis of chronic heart failure.
Gruson D; Ahn SA; Rousseau MF
Peptides; 2015 Feb; 64():24-8. PubMed ID: 25572303
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of biomarkers in chronic kidney disease and chronic heart failure.
Zachariah D; Olechowski B; Kalra PR
J Ren Care; 2013 Sep; 39(3):128-39. PubMed ID: 23902278
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers: Their potential in the diagnosis and treatment of heart failure.
Heil B; Tang WH
Cleve Clin J Med; 2015 Dec; 82(12 Suppl 2):S28-35. PubMed ID: 26694889
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of elderly patients with heart failure.
Manzano L; Escobar C; Cleland JG; Flather M
Eur J Heart Fail; 2012 Oct; 14(10):1097-103. PubMed ID: 22771845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
